PAID CLINICAL TRIAL
- Lasting 13 weeks
- 7-9 clinic visits
YOU MAY BE ELIGIBLE TO PARTICIPATE IF YOU MEET THE FOLLOWING CRITERIA:
-
Have a Diagnosis of Chronic Cough
-
Are 18-80 yrs old
The purpose of this study is to look at whether the investigational study drug, taplucainium, works and how safe it is in adults with refractory chronic cough. Refractory means that treatments have not made it better.
Lynn Institute is a leader in introducing new medications to the market through our clinical trials program. Visit our Participation Information page for Frequently Asked Questions, to see current clinical trials listed, and to find out where each trial is being conducted.
Find out More About Our Participation Program
Participation Information